US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 55.800
  • +0.560+1.01%
Close Sep 9 16:00 ET
  • 55.800
  • 0.0000.00%
Post 16:02 ET
5.14BMarket Cap-7739P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ultragenyx Pharmaceutical Q2 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
123.21M
147.03M
+23.81M
Beat Est.
+13.76%
+35.75%
+19.33%
EPS
-1.65
-1.52
+0.13
Beat Est.
+26.61%
+32.44%
+7.95%
Analyst Rating
Strong Buy

Aug 31, 2024

Ultragenyx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 146.070M--
--2024/Q3-- / 135.247M--
Aug 1, 20242024/Q2147.026M / 123.214M--
May 2, 20242024/Q1108.833M / 116.438M--
Feb 15, 20242023/Q4127.392M / 120.989M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 146.070M--
--2024/Q3-- / 135.247M--
Aug 1, 20242024/Q2147.026M / 123.214M--
May 2, 20242024/Q1108.833M / 116.438M--
Feb 15, 20242023/Q4127.392M / 120.989M--

Unlock Free Earnings Estimates

Ultragenyx Pharmaceutical Earnings Reports

  • Ultragenyx Pharmaceutical | 10-Q: Q2 2024 Earnings Report

    Aug 2 15:36 ET

  • Ultragenyx Pharmaceutical | 10-Q: Q1 2024 Earnings Report

    May 3 15:13 ET

  • Ultragenyx Pharmaceutical | 10-K: FY2023 Annual Report

    Feb 21 16:07 ET

  • Ultragenyx Pharmaceutical | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 18:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 31, 2024

    Strong Buy

    • Buy

      94.74%

    • Hold

      5.26%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg